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Abstract: Osteoarthritis (OA), the most common form of arthritis, is a significant public health burden
in U.S. adults. Among its many risk factors, obesity is a key player, causing inflammation, pain,
impaired joint function, and reduced quality of life. Dietary polyphenols and other bioactive compounds
in berries, curcumin, and tea have shown effects in ameliorating pain and inflammation in OA,
but few clinical studies have been reported. The purpose of the present study was to examine
the effects of dietary strawberries on pain, markers of inflammation, and quality of life indicators
in obese adults with OA of the knee. In a randomized, double-blind cross-over trial, adults with
radiographic evidence of knee OA (n = 17; body mass index (BMI): (mean ± SD) 39.1 ± 1.5; age (years):
57 ± 7) were randomized to a reconstituted freeze-dried strawberry beverage (50 g/day) or control
beverage daily, each for 12 weeks, separated by a 2-week washout phase (total duration, 26 weeks).
Blood draws and assessments of pain and quality of life indicators were conducted using the Visual
Analog Scale for Pain (VAS Pain), Measures of Intermittent and Constant Osteoarthritis Pain (ICOAP),
and Health Assessment Questionnaire-Disability Index (HAQ-DI) questionnaires, which were completed
at baseline and at weeks 12, 14, and 26 of the study. Among the serum biomarkers of inflammation and
cartilage degradation, interleukin (IL)-6, IL-1β, and matrix metalloproteinase (MMP)-3 were significantly
decreased after strawberry vs. control treatment (all p < 0.05). Strawberry supplementation also
significantly reduced constant, intermittent, and total pain as evaluated by the ICOAP questionnaire
as well as the HAQ-DI scores (all p < 0.05). No effects of treatment were noted on serum C-reactive
protein (CRP), nitrite, glucose, and lipid profiles. Dietary strawberries may have significant analgesic
and anti-inflammatory effects in obese adults with established knee OA.
Keywords: strawberries; knee osteoarthritis; pain; inflammation
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1. Introduction
Osteoarthritis (OA), the most common type of arthritis, is a chronic, painful, and inflammatory
musculoskeletal disease causing functional impairment in approximately 27 million Americans; obesity
and advancing age are important risk factors [1,2]. While there is no cure, the current management of
OA combines nonpharmacological and pharmacological interventions, and often involves costly joint
replacement procedures [3]. Non-steroidal anti-inflammatory drugs may lead to gastrointestinal side-effects,
and effective, safer alternatives could benefit millions of patients. Nutraceuticals are good candidates for
the management of OA, due to their safety profile and potential efficacy. However, the popularly used
supplements, such as glucosamine, chondroitin sulfate, and avocado–soy unsaponifiables, have failed to
show a convincing and significant mitigation of symptoms in a meta-analysis of randomized clinical trials,
or lack long-term studies on the clinical symptoms and biomarkers of knee OA [4–6].
Obesity is considered a significant risk factor for OA, and contributes to the chronic inflammation that
underlies the pathogenesis and symptoms of the condition [7,8]. Biomarkers of inflammation, especially
serum C-reactive protein (CRP) and interleukin-6 (IL-6), and those of cartilage degradation, including
matrix metalloproteinases (MMPs), have been positively correlated with pain and the progression of
OA [9–12]. Dietary bioactive compounds, such as curcumin [13,14], ginger [15], green tea polyphenols [16],
and herbal tea [17] have been shown to be effective in the management of pain symptoms and in reducing
inflammatory biomarkers of OA. However, such clinical studies are few in number and of short duration,
mostly examine pain symptoms but not disease biomarkers, and involve non-obese and otherwise
healthy participants. Among the nutritional supplements and foods containing bioactive compounds,
polyphenol-rich dietary berries have been extensively studied for their protective associations with other
chronic conditions, including hypertension [18], type 2 diabetes [19], and overall inflammation [20],
as reported in epidemiological studies. Berries, such as blueberries and red raspberries, have been
shown to reduce the symptoms and progression of arthritis, such as pain and articular degeneration,
in collagen-induced experimental models of arthritis [21,22]. Our group has previously reported the safety
and efficacy of berries, especially freeze-dried blueberries and strawberries, in improving features of the
metabolic syndrome and decreasing surrogate biomarkers of atherosclerosis in clinical studies [23–25].
To our knowledge, no previous clinical study has been reported on the effects of berries on OA of the
knee in adults.
For this reason, we undertook the present study to examine the effects of freeze-dried strawberries
on pain symptoms and on circulating biomarkers of inflammation and cartilage degradation in obese
adults with symptomatic knee OA. Our primary aim was to determine the effects of freeze-dried
strawberries on pain scores assessed by the Visual Analog Scale for Pain (VAS Pain) and those based
on a Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) survey, as well as on selected
biomarkers of inflammation and cartilage degradation associated with knee OA in comparison to
a control group.
2. Materials and Methods
2.1. Participants
Obese participants with a body mass index (BMI) >30 kg/m2 , a large waist circumference (>35 in
for women and >40 in for men), and radiographic evidence of knee OA were enrolled in the study.
A diagnosis of knee OA was verified by a rheumatologist based on the radiological evidence of mild to
moderate bilateral primary knee OA defined by the American College of Rheumatology (ACR) [26].
Radiological evidence of degenerative OA, but without fractures or dislocation, confirmed eligibility
for the study. Participants were excluded if they had any of the following conditions: previous knee
surgery, rheumatoid arthritis, a metabolic disorder (such as diabetes and cancer), liver or kidney failure,
pregnant or lactating, use of corticosteroids and/or intra-articular injections during the preceding
3 months, use of fish oils and glucosamine, participation in a weight loss program in the preceding
6 months, and recent changes in physical activity levels, regular smoking, or allergic to strawberries.
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In addition, participants who were unable to express their pain (such as those with any mental
condition) were also excluded from the study. The study (the ethics approval code: HE1517) was
approved by the ethics committees at the University of Oklahoma Health Sciences Center (OUHSC)
and at Oklahoma State University (OSU). All participants provided written informed consent prior to
enrollment in the study. The trial was registered with clinicaltrials.gov (NCT02518347).
2.2. Study Design and Intervention
Participants were recruited at the Oklahoma Clinical and Translational Sciences Institute (OCTSI) at
OUHSC and at the Department of Nutritional Sciences Clinical Assessment Unit at OSU. The recruitment
was conducted though campus-wide e-mail advertisements and physician referrals. Upon qualification,
the participants were randomly assigned to one of the two study groups in a 26-week crossover study:
strawberry and control. Randomization was performed using a sequence of randomly generated numbers
using SAS (Version 9.4; SAS Institute Inc., Cary, NC, USA). Each intervention was for 12 weeks, with
and intervening two weeks of washout phase. During the active treatment phase, the participants
consumed 50 g of freeze-dried strawberry powder reconstituted in water twice a day. This dose of
strawberry powder is equivalent to approximately 500 g of fresh strawberries, and was previously
used in another study [24]. The control powder was formulated to match the sensory properties of
the strawberry powder as well as its caloric value and macronutrient composition. Table 1 shows the
nutritional composition of the strawberry and control powders provided by the California Strawberry
Commission (Watsonville, CA, USA). The nutrient and phytochemical composition of the strawberry
and control powders was determined at the Robert M. Kerr Food and Agricultural Products Center at
Oklahoma State University (Stillwater, OK, USA), and at the Brunswick Laboratories (Southborough,
MA, USA), respectively. The participants were asked to consume the strawberry or control beverage
twice a day, at similar time points that were at least six to eight hours apart, and also to consume the
beverage as a snack by itself, and not with a meal or other snacks to prevent the confounding effects of
other dietary factors. The participants were instructed to take the last dose of the test beverage at least
10–12 h prior to the fasting blood draw the following morning. The participants were also asked to refrain
from consuming other berry products during the study, and to maintain usual diet and physical activity.
Compliance was assessed by the return of unused test agents and a mandatory three visits per week to
the clinic for supervised consumption and a determination of plasma ellagic acid [27].
Table 1. Composition of the freeze-dried strawberry and control powders 1 .
Nutrients/Compounds

Strawberry Powder

Control Powder

Dose, g
Calories, kcal
Carbohydrates, g
Total polyphenols, mg GAE
Total anthocyanins, mg cyanidin-3-glucoside equivalents
Ellagic acid, mg
Phytosterols, mg
Dietary fiber, g

50
160
35
1585
66
220
50
8

50
172
38
75
5

1

Supplied by California Strawberry Commission (Watsonville, CA, USA); analysis conducted at the Robert M. Kerr
Food and Agricultural Products Center at Oklahoma State University, polyphenol and anthocyanin analyzed by
Brunswick Laboratories (Southborough, MA, USA); GAE: gallic acid equivalents.

2.3. Biochemical Variables
Freshly drawn blood samples were sent to the OU Medical Center laboratory for an analysis of
a comprehensive metabolic panel, including serum glucose, lipid profiles, HbA1c, and high-sensitivity
C-reactive protein (hs-CRP), using an automated clinical analyzer (Abbott Architect Instruments).
Serum IL-6, IL-1β, and MMP-3 and 8 were measured using ELISA kits based on the manufacturer’s
protocol (R&D Systems, Minneapolis, MN, USA) with inter-assay CVs (Coefficient of variation) of
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4.5%, 7.6%, 3.6%, and 7.5%, respectively. Serum nitrite was measured using the Griess Reagent System
(Promega Corporation, Madison, WI, USA) with a mean inter-assay CV of 3.3%.
2.4. Pain Scores and Quality of Life Indicators
Knee pain scores were assessed using the ICOAP survey, a multidimensional, OA-specific measure
designed to provide a comprehensive evaluation of pain experience in people with knee OA, that has
been used in several large studies [28,29]. The ICOAP is an 11-item scale evaluating two pain domains:
a 5-item scale evaluating constant pain and a 6-item scale evaluating intermittent pain. We also
used the VAS Pain and health scale to assess the visual perception of the participants’ pain intensity
and feeling of well-being [30]. In addition, the Health Assessment Questionnaire-Disability Index
(HAQ-DI) was used to assess functional ability using 20 items distributed across eight dimensions
(dressing, arising, eating, walking, reach, grip, hygiene, and daily activity), rating each according to
a four-level disability scale (range 0–3) [30]. The participants were asked to fill out the questionnaires
on the morning of their fasting blood draws visits, at least 10–12 h following their last test dose of
strawberry and control beverage.
2.5. Dietary Analysis
Habitual intake of food and beverages was recorded using 3-day food records (two weekdays
and one weekend day) at baseline, and at week 6, 12, 14, 20, and 26 of the study. At enrollment,
the participants were educated to record food and beverages by a study Registered Dietitian (RD)
using food models and utensils for the estimation of portion sizes. Nutrient intakes were analyzed
using Nutritionist Pro version 3.2 (Axxya Systems LLC, Redmond, WA, USA). The averages of three
days were used to estimate the nutrient intakes per week for each participant.
2.6. Statistical Analysis
For baseline demographics and characteristics, continuous variables were expressed as means ± SD
and discrete variables were presented as counts and proportions. Our main objective was to assess whether
the selected biomarkers of inflammation and cartilage degradation, as well as knee pain scores, were
different between the strawberry and control phases at 12 vs. 26 weeks of the crossover study. To test
this aim, we used a linear mixed-effects model (PROC MIXED) with time as within-subject factor and
intervention group as a between-subject factor for each variable. Data were corrected for baseline values.
We also examined associations of the serum biomarkers with knee pain scores at baseline using a multiple
linear regression model, adjusting for baseline age, BMI, and energy intake. The assumptions used in the
sample size calculation were conservative, based on the report by Panahi et al. [13]. From previous dietary
intervention studies in knee OA, we expected a decrease in serum IL-6 in the range of 0.39–0.45 pg/mL [31].
All p-values < 0.05 were considered statistically significant and data were analyzed using SAS/STAT
software (Version 9.4; SAS Institute Inc., Cary, NC, USA).
3. Results
Among the 35 participants who were screened, 17 qualified and completed the 26-week study
(Figure 1). The baseline characteristics of these participants are shown in Table 2. There were no
drop-outs in the study. Among the participants who completed the study, compliance was 100% for
the strawberry group and 97% for the control group as assessed by mandatory thrice weekly visits,
with the return of any unconsumed strawberry and control powder on the days the participants did
not come to the clinic. No adverse events were reported in the study. As a measure of compliance,
plasma ellagic acid was detectable in 17 participants in the strawberry phase (means ± SEMs (Standard
error of means), 30.2 ± 3.6 ng/mL), whereas concentrations were not detectable at baseline, at the end
of washout, and at the end of the control phase.
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profiles, and liver and kidney function tests did not differ between the strawberry and control phases
of the crossover study.
Table 3. Baseline associations of knee pain scores and Health Assessment Questionnaire-Disability Index
with selected markers of inflammation and cartilage degradation in obese adults with symptomatic
knee osteoarthritis (linear regression coefficients) (n = 17).
Serum Variable

ICOAP (Constant Pain) %

ICOAP (Intermittent Pain) %

ICOAP (Total Pain) %

HAQ-DI

hs-CRP (mg/L)
p-value *

1.9 ± 1.3
0.18

1.7 ± 1.4
0.24

1.8 ± 1.1
0.25

0.03 ± 0.04
0.28

IL-6 (pg/mL)
p-value

5.7 ± 2.8
0.03

1.8 ± 2.9
0.23

3.6 ± 2.4
0.37

0.003 ± 0.08
0.42

IL-1β (pg/mL)
p-value

0.4 ± 0.3
0.21

0.04 ± 0.3
0.32

0.2 ± 0.1
0.42

0.003 ± 0.007
0.46

MMP-3 (ng/mL)
p-value

1.6 ± 1.7
0.34

1.9 ± 1.8
0.23

1.8 ± 1.5
0.21

0.03 ± 0.05
0.53

MMP-8 (ng/mL)
p-value

2.7 ± 3.4
0.32

6.9 ± 3.5
0.006

5.0 ± 2.9
0.42

0.01 ± 0.09
0.21

Values are estimate (beta) ± standard error (SE) obtained from a multiple linear regression model; For each serum
variable, the model was adjusted for the remaining variables of inflammation and cartilage degradation in the
model, as well as baseline age, body mass index (BMI), waist circumference, and energy intake as covariates;
* p < 0.05 in bold; hs-CRP, high sensitivity C-reactive protein; IL-6: interleukin-6; IL-1β: interleukin-1β; MMP: matrix
metalloproteinase; ICOAP: intermittent and constant osteoarthritis pain; HAQ-DI: health assessment questionnaire
disability index.

Table 4. Anthropometrics and serum biochemical and inflammatory profiles following strawberry and
control interventions in a 26-week crossover trial in obese adults with symptomatic knee osteoarthritis
(n = 17/group).
Variables

Baseline

Strawberry
(12-Week)

Washout
(2-Week)

Control
(12-Week)

p-Value *

BMI (kg/m2 )
Body weight (lb)
Waist circumference (inches)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Fasting glucose (mg/dL)
HbA1c (%)
Total Cholesterol (mg/dL)
LDL Cholesterol (mg/dL)
HDL Cholesterol (mg/dL)
Triglycerides (mg/dL)
ALT (U/L)
AST (U/L)
Creatinine (mg/dL)
BUN (mg/dL)
hs-CRP (mg/L)
IL-6 (pg/mL)
IL-1β (pg/mL)
MMP-3 (ng/mL)
MMP-8 (ng/mL)
Nitrite (µM)

39.1 ± 1.5
246.4 ± 7.3
46.4 ± 1.1
125 ± 3.0
80 ± 2.0
113.4 ± 5.6
5.9 ± 0.2
189 ± 6.2
109 ± 6.3
51 ± 3.0
129 ± 14.3
40.5 ± 2.8
30.1 ± 2.6
0.75 ± 0.03
15.5 ± 0.9
5.7 ± 1.2
8.8 ± 0.4
18.6 ± 4.0
6.9 ± 0.6
1.8 ± 0.3
6.4 ± 0.7

39.3 ± 1.4
245.6 ± 7.4
46.5 ± 1.1
125 ± 2.0
82 ± 1.0
118.9 ± 8.7
6.1 ± 0.1
188 ± 7.6
108 ± 6.9
52 ± 2.9
136 ± 16.1
38.6 ± 2.3
28.9 ± 2.3
0.78 ± 0.03
14.5 ± 0.7
4.6 ± 0.9
3.4 ± 0.5
7.5 ± 0.7
5.3 ± 0.5
2.2 ± 0.3
9.9 ± 2.2

39.3 ± 1.5
245.1 ± 7.1
46.1 ± 1.0
126 ± 3.0
81 ± 2.0
114.7 ± 4.5
5.99 ± 0.2
182 ± 7.0
105 ± 6.8
50 ± 2.5
128 ± 15.0
39.5 ± 2.1
28.6 ± 1.7
0.75 ± 0.03
15.3 ± 1.0
5.4 ± 1.1
8.1 ± 0.9
16.3 ± 3.1
7.1 ± 0.6
2.4 ± 0.2
6.4 ± 0.8

39.3 ± 1.5
245.0 ± 7.2
46.8 ± 1.1
127 ± 2.0
82 ± 1.0
112.3 ± 5.1
6.1 ± 0.2
188 ± 8.7
105 ± 7.6
54 ± 3.3
130 ± 12.9
40.6 ± 2.9
31.4 ± 2.1
0.77 ± 0.02
14.5 ± 1.0
4.8 ± 0.8
8.7 ± 1.4
16.2 ± 1.2
6.8 ± 0.5
2.1 ± 0.2
7.5 ± 0.8

0.41
0.32
0.26
0.37
0.41
0.31
0.88
0.86
0.65
0.12
0.54
0.42
0.52
0.42
0.36
0.74
0.006
<0.0001
0.004
0.26
0.23

Values are means ± SEMs (Standard error of means) obtained from a linear mixed-effects model with time as
within-subject factor and intervention group as a between-subject factor; * Strawberry 12-week vs. Control 12-week
adjusted for Baseline; p < 0.05 in bold; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body
mass index; BUN: blood urea nitrogen; hs-CRP, high sensitivity C-reactive protein; IL-6: interleukin-6; IL-1β:
interleukin-1β; MMP: matrix metalloproteinase.

As shown in Table 5, the pain scores and HAQ-DI ratings were lower in the strawberry vs.
control phase of the study. The knee pain scores measured as constant, intermittent, and total pain
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using ICOAP surveys were significantly lower following the strawberry vs. control phase at week 12
(p < 0.05, Table 5). No differences were noted in the VAS pain scores. Among the surveys related
to general health and disability index, the HAQ-DI ratings were again significantly lower in the
strawberry vs. control phase at week 12 (p < 0.05, Table 5). The VAS health scores were not affected by
the strawberry treatment.
Table 5. Measures of knee pain and quality of life indicators following strawberry and control interventions
in a 26-week crossover trial in obese adults with symptomatic knee osteoarthritis (n = 17/group).
Variables

Baseline

Strawberry
(12-Week)

Washout
(2-Week)

Control
(12-Week)

p-Value *

HAQ-DI
VAS PAIN
VAS HEALTH
ICOAP (Constant pain) %
ICOAP (Intermittent pain) %
ICOAP (Total pain) %

0.6 ± 0.1
1.4 ± 0.2
0.7 ± 0.1
31.8 ± 3.5
38.5 ± 3.4
35.4 ± 3.1

0.4 ± 0.1
0.8 ± 0.1
1.0 ± 0.2
13.8 ± 3.6
24.3 ± 4.7
19.4 ± 3.7

0.5 ± 0.1
1.1 ± 0.1
0.9 ± 0.2
32.1 ± 3.7
34.1 ± 2.2
33.2 ± 2.2

0.6 ± 0.1
1.0 ± 0.2
0.7 ± 0.1
24.2 ± 4.1
34.6 ± 3.0
29.9 ± 3.0

0.026
0.17
0.13
0.01
0.02
0.007

Values are means ± SEMs obtained from a linear mixed-effects model with time as within-subject factor and
intervention group as a between-subject factor; * Strawberry 12-week vs. Control 12-week adjusted for Baseline;
p < 0.05 in bold; ICOAP: intermittent and constant osteoarthritis pain; HAQ-DI: health assessment questionnaire
disability index; VAS: visual analog scale.

The dietary data did not reveal any significant differences in the mean intake of macro- and
micro-nutrients throughout the study (Table 6). No crossover effects were detected on any of the
outcome variables.
Table 6. Dietary nutrient intakes in a 26-week crossover trial in obese adults with symptomatic knee
osteoarthritis (n = 17/group).
Nutrients

Baseline

Strawberry
(12-Week)

Washout
(2-Week)

Control
(12-Week)

p-Value *

Calories (kcal)
Carbohydrates (g)
Fats (g)
Proteins (g)
Saturated fats (g)
MUFA (g)
PUFA (g)
Fiber (g)
Vitamin C (mg)
Vitamin E (mg)
Beta-carotene (µg)

2026 ± 183
215 ± 19
90 ± 12
92 ± 11
30 ± 4
17 ± 4
8±2
18 ± 2
45 ± 9
5±2
590 ± 303

2604 ± 441
320 ± 56
100 ± 22
107 ± 19
32 ± 6
22 ± 6
12 ± 3
23 ± 3
81 ± 17
7±2
890 ± 203

2004 ± 184
216 ± 20
89 ± 12
96 ± 10
28 ± 3
17 ± 4
7 ± 1.5
19 ± 2
42 ± 9
4±1
580 ± 311

1901 ± 203
228 ± 29
78 ± 9
76 ± 7
26 ± 3
13 ± 3
6±2
20 ± 3
75 ± 28
5±2
828 ± 400

0.12
0.21
0.31
0.43
0.31
0.18
0.11
0.43
0.77
0.34
0.63

Values are means ± SEMs obtained from a linear mixed-effects model with time as within-subject factor and
intervention group as a between-subject factor; * Strawberry 12-week vs. Control 12-week adjusted for Baseline;
MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids.

4. Discussion
To our knowledge, this is the first clinical study on the effects of dietary berries as a nutritional
supplement on pain scores and key biomarkers of inflammation in obese adults with radiographic
evidence of knee OA. Using a multi questionnaire approach, strawberry supplementation led to
significant decreases in constant, intermittent, and total knee pain scores, and an improved disability
index and overall health scores. Serum biomarkers of inflammation and cartilage degradation that have
been associated with pain and dysfunction in knee OA, especially IL-6, IL-1β, and MMP-3, were also
shown to be significantly lower in the strawberry-supplemented group. These findings support a role
for foods high in bioactive compounds, such as strawberries, as an alternative or complementary
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treatment option in pain management that may also reduce surrogate markers of disease progression
in knee OA.
Pain relief is one of the major targets of OA management. Symptoms of pain in OA are associated
with inflammation and oxidative stress, cartilage degradation, and joint space narrowing [32–34]. It is
therefore logical to propose that antioxidant supplements may be of benefit. Strawberries are naturally
rich in antioxidant polyphenols, and thus were selected for our study [35]. Participants rated their pain in
the range of mild to moderate intensity at baseline using the VAS as well as the ICOAP questionnaires.
Other polyphenol containing supplements, such as curcumin [13,36], green tea [16], and herbal tea
supplements [17], have also shown significant decreases in knee pain scores in participants with similar
intensity of knee pain as in our study. However, none of these studies reported effects on systemic markers
of inflammation and disease progression underlying knee OA.
Together with previous reports, our findings support the analgesic effects of dietary polyphenols
in adults with mild to moderate knee pain. Pain measurement in OA has been largely determined by
questionnaires, such as those based on quality of life indicators. Meanwhile, physical examination
and radiography have been used to stage the disease. We used the VAS, HAQ-DI, and ICOAP
questionnaires: these have been widely employed to assess knee pain, quality of life, and disability in
adults with OA [29,30]. The ICOAP questionnaire is endorsed by the Osteoarthritis Research Society
International (OARSI). It has been validated in large multi-country studies, and correlates well with
other commonly used methods, such as the Western Ontario and McMaster Universities’ Osteoarthritis
Index (WOMAC) scores [28,37]. Based on our study findings, strawberries consistently improved pain
scores as observed across all three sub-scales of ICOAP, evaluating constant, intermittent, and total
pain; they also lowered HAQ-DI scores, reflecting functional improvement. We did not observe any
difference in pain scores assessed by VAS survey in our participants. These differences could be
explained by the visual expression of general pain intensity used in VAS scoring, when compared to
the OA-specific magnitude of knee pain numerically rated by the ICOAP questionnaires. Based on the
strengths and limitations of each assessment tool for pain, it is generally recommended to administer
more than one questionnaire to capture the multi-dimensional aspects of adult pain. These findings
merit follow up in larger trials to validate the findings.
Inflammation is believed to play a pivotal role in the pathophysiology of OA. Multiple cytokines
and inflammatory molecules, especially CRP, IL-6, and IL-1β, and free radicals, such as nitric oxide, are
implicated in the progression of OA [38,39]. Inflamed chondrocytes then produce MMPs, leading to
cartilage degradation and progression of OA [40]. In experimental models of OA, green tea, curcumin,
and some herbal supplements may reduce inflammatory molecules and MMPs [41,42], while few
of the reported clinical studies have determined the effects of the dietary bioactive compounds on
inflammatory mediators. In a 16-week study assessing the effects of a high-polyphenol rosmarinic acid
tea on pain in participants with knee OA, serum CRP was reported only at baseline but not after the
intervention [17]. Among the studies showing improvements in knee pain in OA following curcumin
supplementation [13,43,44], only one study reported data on inflammatory markers, including
IL-6; however, these did not differ between the intervention and placebo groups after six weeks’
treatment [43]. Thus, the study of inflammatory mediators is limited in previous reports of dietary
supplements for OA.
In our study, 12 weeks of strawberry supplementation resulted in a significant decrease in IL-6,
IL-1β, and MMP-3 in obese participants with knee OA, consistent with anti-inflammatory effects of
dietary berries in OA management. These clinical observations are consistent with data showing that
blueberry and raspberry extracts lower pain, inflammation, and edema, and articular destruction in
experimental arthritis [21,22]. Metalloproteinases zinc-dependent enzymes (MMPs) play a key role in
extracellular matrix remodeling and cartilage metabolism in knee OA. Among the various isoforms of
MMPs, MMP-3 plays an important role in cartilage degradation, and has been shown to be responsive
to therapeutic agents in patients with various stages of OA [12,45,46]. On the other hand, MMP-8
has been implicated in the degradation of already compromised cartilage matrix, and a few clinical
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studies have examined its response to therapeutic agents, and revealed conflicting results [45,47,48].
Thus, future studies must address the role of dietary polyphenolic compounds on a comprehensive
panel of serum MMPs to identify clinically responsive biomarkers in OA management.
Obesity has been strongly correlated with knee OA, and consequently weight loss studies,
especially the Intensive Diet and Exercise for Arthritis (IDEA) trial, have demonstrated significant
decreases in IL-6 and improvements in knee pain and function following diet and exercise interventions
in obese older adults [31]. Interestingly, the magnitude of the decrease in serum IL-6 in our study
following the 12-week strawberry intervention was much larger than what was noted in the IDEA trial
following an 18-month lifestyle intervention [31]. IL-6 is a key inflammatory molecule that accelerates
articular degradation and OA progression, and higher levels of systemic IL-6 are a significant predictor
of OA [49]. Furthermore, a reduction of IL-6 levels can significantly improve the metabolic syndrome,
also considered a risk factor of OA [50]. The IDEA trial also reported a concomitant decrease in CRP
in obese older adults undergoing 5% total weight and fat mass loss following a dietary and exercise
intervention [51]. However, CRP was not significantly altered in the present study, and it may be that
weight loss is essential to affect this marker of inflammation. Future studies must assess the combined
effects of antioxidant bioactive compounds with weight loss in improving inflammatory profiles in
knee OA.
Our study has limitations that affect the interpretation and generalizability of our findings.
These include a small sample size, the absence of a dose–response design to assess effects at low vs. high
dose of strawberries, and the absence of a non-OA control group. Participants had mild-to-moderate
radiographic knee OA at baseline (Kellgren–Lawrence scores of 2.1) and mild-to-moderate knee pain.
Whether patients with more severe knee OA (Kellgren–Lawrence score of 4) and higher levels of pain
would benefit from strawberry intervention needs further investigation. We did not measure other
biomarkers of OA pathology, such as those related to oxidative damage, or simultaneously measure
these biomarkers in synovial fluid that would provide a more accurate determination of changes
specific to the knee. Also, we did not assess the radiological outcomes at the end of the intervention.
Also, being conducted in obese participants with mild-to-moderate symptoms of knee OA, our study
findings may not be generalizable to the non-obese population or OA caused by sports injuries and
other trauma, or to those needing pain relief after knee surgery.
The strengths of our study include a randomized, controlled cross-over study design, which accounts
for most of the inter-individual variations in parallel arm studies. Also, based on the administration
of a control powder that matched the freeze-dried strawberries in sensory qualities, we were able to
keep the participants and study coordinators blinded to the identity of the test agents. In addition,
we excluded participants who were taking supplements, such as fish oil and other herbal supplements for
pain relief, as well as those participating in a weight loss program, and thus were able to exclude potential
confounding by these factors.
5. Conclusions
In conclusion, our pilot study provides evidence on the role of strawberry bioactive compounds,
as a rich source of polyphenols and nutrients, in improving pain and inflammation in obese adults
with mild-to-moderate knee OA when compared to a control group. Given the economic burden of
obesity and related conditions, including knee OA, our study suggests that simple dietary intervention,
i.e., the addition of berries, may have a significant impact on pain, inflammation, and overall quality
of life in obese adults with OA.
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